Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTungsten west Regulatory News (TUN)

Share Price Information for Tungsten west (TUN)

Share Price is delayed by 15 minutes
Get Live Data
38.75    -0.55 (-1.40%)
Bid:
38.50
Ask:
39.00
Spread: 0.50 (1.299%)
Market Cap: £483.47m
TUN Live PriceLast checked at - London Stock Exchange

Intraday Tungsten west Share Chart

Convertible Loan Note Update

17 Oct 2024 12:40

RNS Number : 6372I
Tungsten West PLC
17 October 2024
 

 

17 October 2024

Tungsten West Plc

("Tungsten West", the "Company" or the "Group")

 

 Convertible Loan Note Update

 

Tungsten West (LON:TUN), the mining company focused on restarting production at the Hemerdon tungsten and tin mine ("Hemerdon" or the "Project") in Devon, UK, is pleased to announce that it has raised £2.00 million by way of adding an additional tranche ("Tranche F") to the existing 2023 Convertible Loan Notes ("CLNs").

 

The CLNs have been further amended and restated ("Third Amended CLN") to include an additional Tranche F on substantially the same terms as the Tranches A, B, C, D and E of the CLNs, as announced 19 May 2023, 18 December 2023, 28 March 2024 and 23 July 2024. The maturity date of the notes is 31 January 2025. Further to the announcement on 23 July 2024 in relation to Tranche E of the CLNs, the Company confirms the closing of Tranche E immediately prior to Tranche F, for the amount of £2.9 million.

 

The proceeds of Tranche F will be used to continue work on the targeted scope feasibility work required to build a robust plan and economic assessment which the Company expects to complete by early 2025. The full feasibility study, if required, will also be completed in early 2025, leading to a financing round in H1 2025 which will enable the Company to recommence production of tungsten and tin in H2 2026.

 

As noted in the Chairman's statement in the audited financial results, the Company continues to explore funding from certain export Credit Agencies in the UK, US and individual states within the EU along with other potential capital providers. The Company recently received a Letter of Interest from one of the counterparties it has been engaging with and will now progress with submitting a formal application. Whilst this is a positive development, it is only a preliminary step in a long process and there can be no guarantee of success.

 

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014 as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019.

 

 

Ends

 

For further information, please contact:

 

Enquiries

Tungsten West

Alistair Stobie

Tel: +44 (0) 1752 278500

 

Strand Hanson

(Nominated Adviser and Financial Adviser)

James Spinney / James Dance / Abigail Wennington

Tel: +44 (0) 207 409 3494

BlytheRay

(Financial PR)

Tim Blythe / Megan Ray

Tel: +44(0) 20 7138 3204

Email: tungstenwest@blytheray.com

 

Hannam & Partners

(Broker)

Andrew Chubb / Matt Hasson / Jay Ashfield

Tel: +44 (0)20 7907 8500

 

Follow us on X @TungstenWest

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBBBDGCXBDGSR
Date   Source Headline
7th Nov 20257:00 amRNSSuccessful Processing Trial
29th Sep 20256:20 pmRNSResults of Annual General Meeting
25th Sep 20257:00 amRNSNotice of Annual General Meeting
23rd Sep 20257:00 amRNSBoard Change
4th Sep 20253:02 pmRNS-RInvestor Presentation and Q&A
4th Sep 20257:00 amRNSFinancial Results for the Year Ended 31 March 2025
3rd Sep 20254:30 pmRNSTR-1: Notification of major holdings
28th Aug 20257:00 amRNSLoI from Export-Import Bank of the United States
5th Aug 20257:00 amRNSCompletion of Updated Feasibility Study
18th Jul 20252:50 pmRNSTR-1: Notification of major holdings
2nd Jul 20253:00 pmRNSConvertible Loan Note Update
16th Jun 20259:35 amRNS-RCorporate Presentation
10th Jun 202512:22 pmRNSTR1: Notification of major holdings
10th Jun 20257:00 amRNSDirector Dealings
5th Jun 20257:00 amRNSHemerdon designated a Strategic Project under CRMA
30th May 20257:00 amRNSDevelopment and Economic Plan for Hemerdon
28th May 20258:58 amRNSChange of Registered Address
8th May 20257:00 amRNSConvertible Loan Note Update
13th Jan 20251:20 pmRNSConvertible Loan Note Update
31st Dec 202412:41 pmRNSHalf Year Results
4th Dec 20247:00 amRNSAppointment of Chairman
3rd Dec 20244:05 pmRNSResults of Annual General Meeting
8th Nov 20243:19 pmRNSAmendment to Notice of AGM
1st Nov 20241:02 pmRNSNotice of Annual General Meeting
17th Oct 202412:40 pmRNSConvertible Loan Note Update
8th Oct 20247:00 amRNSDirectorate Change
2nd Oct 202412:00 pmRNSFinancial Results & Lifting of Trading Suspension
2nd Oct 202412:00 pmRNSRestoration - Tungsten West PLC
1st Oct 202410:08 amRNSTemporary Suspension of Trading on AIM
1st Oct 20247:30 amRNSSuspension - Tungsten West plc
15th Aug 20247:00 amRNSAppointment of Chief Executive Officer
23rd Jul 20247:00 amRNSConvertible Loan Note Update
3rd Jul 20247:00 amRNSBoard Changes
12th Jun 20247:00 amRNSMineral Processing Facility Permit Awarded
5th Jun 20247:00 amRNSBoard Change
20th May 20247:00 amRNSExercise of Options
8th May 20244:03 pmRNSExtension of EA public consultation period
28th Mar 20247:00 amRNSConvertible Loan Note Update
25th Mar 20242:00 pmRNSCommencement of EA public consultation period
7th Feb 20247:00 amRNSTR-1: Notification of major holdings
5th Feb 20247:00 amRNSReceipt of Draft Permit for MPF
22nd Dec 20237:00 amRNSHalf Year Results
18th Dec 20237:00 amRNSConvertible Loan Note Update
10th Nov 20237:00 amRNSAppointment of Chief Financial Officer
10th Oct 20234:45 pmRNSResults of Annual General Meeting
15th Sep 20233:45 pmRNSNotice of AGM
14th Sep 20237:00 amRNSFinal Results for the year ended 31 March 2023
4th Sep 202310:28 amRNSAppointment of Non-Executive Directors
16th Aug 20237:00 amRNSProject Update
16th Aug 20237:00 amRNSDirectorate and Management Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.